InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Lawson Byron, Directeur Commercial. Director active across 1 company, notably HTG Molecular Diagnostics, INC. Aggregated, 9 filings have been recorded. Activity tracked since 10 June 2021. The latest transaction was filed on 9 December 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Lawson Byron
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
1,000 shares@ US$0.4254.2% of flowCommon StockSEC:0001209191-22-061009:0
23 shares@ US$1.030.2% of flowCommon StockSEC:0001209191-22-040341:0
1,000 shares@ US$0.4764.9% of flowCommon StockSEC:0001209191-22-036956:0
23 shares@ US$1.390.6% of flowCommon StockSEC:0001209191-22-022392:0
24 shares@ US$5.422.2% of flowCommon StockSEC:0001209191-22-000857:0
896 shares@ US$3.561554.1% of flowCommon StockSEC:0001209191-21-069780:0
24 shares@ US$5.712.3% of flowCommon StockSEC:0001209191-21-058992:0
24 shares@ US$5.812.3% of flowCommon StockSEC:0001209191-21-045190:0
354 shares@ US$3.918521.8% of flowCommon StockSEC:0001209191-21-040446:0
9 of 9 declarations
About Lawson Byron
Byron Lawson is Senior Vice President and Chief Commercial Officer at HTG Molecular Diagnostics, Inc. He oversees commercial operations, playing a key role in growth strategy and business development.
